Brown T J, Power E G, French G L
Department of Microbiology, St Thomas' Hospital, London, UK.
J Clin Pathol. 1999 Mar;52(3):193-7. doi: 10.1136/jcp.52.3.193.
To assess the performance of three commercially available Mycobacterium tuberculosis detection systems employing nucleic acid amplification, when applied directly to respiratory and non-respiratory specimens from patients where the diagnosis of tuberculosis is difficult using clinical and traditional bacteriological methods.
42 respiratory and 21 non-respiratory specimens were concentrated, examined with auramine staining, and cultured on Lowenstein-Jensen slopes. These specimens were also assayed using the Amplicor Mycobacterium tuberculosis test (AM) (Roche Diagnostic Systems), the Amplified Mycobacterium tuberculosis direct test (AMD) (Gen-Probe), and the LCx Mycobacterium tuberculosis assay (LMA) (Abbott Laboratories).
All three amplification systems used in this study gave specificities of 100% when used on respiratory specimens. When used on non-respiratory specimens, AM and LMA gave specificities of 100% and AMD 75%. With respiratory specimens the AM, AMD, and LMA systems gave sensitivities of 75%, 65.2%, and 79.2%, respectively. With non-respiratory specimens the sensitivities were 50%, 66.7%, and 60%, while with smear negative, culture positive specimens they were 33.3%, 66.7%, and 55.6%. Positive predictive values of 100% were seen with all specimens except non-respiratory specimens assayed using AMD where the value was 66.7%.
The manufacturers of these systems recommend that they should only be used for the direct analysis of respiratory specimens, and the US Food and Drug Administration has approved them for use only with smear positive specimens. This study confirms that sensitivities are lower for non-respiratory and smear negative specimens, but positive predictive values are high. Provided they are interpreted with caution, positive results with these tests in respiratory and non-respiratory specimens are useful in tuberculous patients who are otherwise difficult to diagnose. Each amplification has advantages and disadvantages compared with the others.
评估三种市售的采用核酸扩增技术的结核分枝杆菌检测系统,将其直接应用于临床和传统细菌学方法难以诊断结核病的患者的呼吸道和非呼吸道标本时的性能。
对42份呼吸道标本和21份非呼吸道标本进行浓缩处理,用金胺染色检查,并接种于罗-琴培养基斜面上培养。这些标本还用罗氏诊断系统公司的结核分枝杆菌扩增检测试剂盒(AM)、基因探针公司的结核分枝杆菌直接扩增检测试剂盒(AMD)和雅培实验室的LCx结核分枝杆菌检测试剂盒(LMA)进行检测。
本研究中使用的所有三种扩增系统用于呼吸道标本时特异性均为100%。用于非呼吸道标本时,AM和LMA的特异性为100%,AMD为75%。对于呼吸道标本,AM、AMD和LMA系统的灵敏度分别为75%、65.2%和79.2%。对于非呼吸道标本,灵敏度分别为50%、66.7%和60%,而对于涂片阴性、培养阳性的标本,灵敏度分别为33.3%、66.7%和55.6%。除使用AMD检测的非呼吸道标本的阳性预测值为66.7%外,所有标本的阳性预测值均为100%。
这些系统的制造商建议它们仅应用于呼吸道标本的直接分析,且美国食品药品监督管理局仅批准其用于涂片阳性标本。本研究证实,非呼吸道标本和涂片阴性标本的灵敏度较低,但阳性预测值较高。只要谨慎解读结果,这些检测在呼吸道和非呼吸道标本中得到的阳性结果对于其他难以诊断的结核病患者是有用的。与其他扩增方法相比,每种扩增方法都有其优缺点。